CNBC World

Court rules companies can't import Gilead medications from overseas in blow to AFP health programs

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

Ontario free to axe Toronto bike lanes, region’s top court rulesWorldPing
The Guardian

Ontario free to axe Toronto bike lanes, region’s top court rules

Win is significant for region’s premier, Doug Ford, who blames protected zones for city’s traffic ills The Ontario government is now free to rip out Toronto’s bike lanes on its busiest streets after the region’s top court ruled in favour of the provi…

Brief by WorldPing · Original reporting by The Guardian